Acorda Therapeutics Indenture Agreements

3 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Indenture for 6.00% Convertible Senior Secured Notes due 2024 – Acorda Therapeutics, Inc., Guarantors, and Wilmington Trust
Indenture Agreements
Acorda Therapeutics
Biotechnology
DE
2019
First Supplemental Indenture to 1.75% Convertible Senior Notes Due 2021 between Acorda Therapeutics, Inc. and Wilmington Trust, N.A.
Indenture Agreements
Acorda Therapeutics
Biotechnology
DE
2014
Indenture Agreement between Acorda Therapeutics, Inc. and Wilmington Trust, National Association (June 23, 2014)
Indenture Agreements
Acorda Therapeutics
Biotechnology
DE
2014